Company data
Cogent Biosciences, Inc. employees and revenue per employee
COGT · Biotechnology · $5.30B market cap
Cogent Biosciences, Inc. had 15 employees at the end of fiscal Dec 2020, down 79.2% from a year earlier. Revenue for the year was $7.9M, down 65.0% from a year earlier, or $525K per employee. Revenue fell, and headcount fell or held flat with it.
The latest annual report we hold is more than two years old, so these numbers may be out of date.
Employees
15
-79.2% YoY
Revenue
$7.9M
-65.0% YoY
Revenue / employee
$525K
Peer median $546K
Rank in industry
25 of 47
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2020 | 15 | $7.9M | $525K | -79.2% | -65.0% |
| Dec 2019 | 72 | $22.5M | $312K | +28.6% | +131.1% |
| Dec 2018 | 56 | $9.7M | $174K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Cogent Biosciences, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| COGT Cogent Biosciences, Inc. | 15 | $7.9M | $525K | Contracting |
| KYMR Kymera Therapeutics, Inc. | 238 | $39.2M | $165K | Hiring into decline |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
| IMNM Immunome, Inc. | 177 | $6.9M | $39K | Hiring into decline |
| CGON CG Oncology Inc. | 142 | $4.0M | $28K | Efficient growth |
| DNTH Dianthus Therapeutics, Inc. | 92 | $2.0M | $22K | Hiring into decline |
| CRNX Crinetics Pharmaceuticals, Inc. | 594 | $7.7M | $13K | Efficient growth |
Questions about Cogent Biosciences, Inc.
- How many employees does Cogent Biosciences, Inc. have?
- Cogent Biosciences, Inc. reported 15 employees for the fiscal year ending Dec 2020, in the annual report it filed on March 16, 2021. That is down 79.2% from a year earlier.
- What is Cogent Biosciences, Inc.'s revenue per employee?
- Cogent Biosciences, Inc. brought in $7.9M of revenue in fiscal Dec 2020, which is $525K per employee. That ranks 25 of 47 companies we track in Biotechnology, where the median is $546K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare COGT with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Cogent Biosciences, Inc.'s annual reports (Form 10-K), latest filed March 16, 2021. This is data, not a recommendation to buy or sell COGT.